Catalent Inc Stock News

Aptus Capital Advisors' Dave Wagner joins 'Power Lunch' to discuss how to trade three stocks making headlines today: Johnson & Johnson, Catalent, and Lockheed Martin.

Catalent (CTLT) issues a profit warning for third-quarter fiscal 2023 amid supply chain disruptions and operational challenges. It also announces the departure of its CFO.

A media report said that a potential suitor has abandoned its efforts to acquire the specialty healthcare services provider. That party isn't entirely giving up on its chase, however.

CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Catalent and Moderna.

Friday's session is marked by rising risk aversion in the U.S. stock market, with all U.S. major indices in the red, despite some of the biggest U.S. financial institutions posting better-than-e

Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday. CXApp Inc. (NASDAQ: CXAI) shares jumped 138% to $16.80 after gaining more than 345% on Th

JP Morgan leads a really in banks stocks after better-than-expected earnings.

Catalent Inc (NYSE: CTLT) announced the departure of its CFO, Thomas Castellano. Search for another CFO is underway. Ricky Hopson, the company's President, Division Head for Clinical Development &

Drug manufacturer Catalent said higher-than-expected costs and productivity issues at three plants would have a material adverse impact on fiscal third-quarter earnings.

U.S. stocks traded mixed this morning, following the release of economic reports. Following the market opening Friday, the Dow traded up 0.08% to 34,055.40 while the NASDAQ fell 0.10% to 12,153.84. Th

Catalent has warned its financial performance is set to be impacted by productivity issues and higher-than-expected costs at three of its facilities, including two of its largest manufacturing facilit

Catalent Inc.'s stock CTLT, -1.46% tumbled 20% in premarket trade Friday, after the provider of services to the pharma industry issued a profit warning for its fiscal third quarter through March 31. T

Catalent's (CTLT) product and service launches, and a slew of strategic deals raise optimism about the stock.

Catalent's (CTLT) product and service launches, and a slew of strategic deals raise optimism about the stock.

Upgrades For Regions Financial Corp (NYSE:RF), UBS upgraded the previous rating of Neutral to Buy. Regions Finl earned $0.67 in the fourth quarter, compared to $0.44 in the year-ago quarter. The curre